{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:08:59Z","timestamp":1783573739945,"version":"3.55.0"},"reference-count":80,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health & Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50HD071836"],"award-info":[{"award-number":["P50HD071836"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P51ODO11092"],"award-info":[{"award-number":["P51ODO11092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH National Center for Advancing Translational Science","award":["UL1TR001881"],"award-info":[{"award-number":["UL1TR001881"]}]},{"name":"NIH National Center for Advancing Translational Science","award":["1R01AG080516"],"award-info":[{"award-number":["1R01AG080516"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Adipose steroid metabolism modifies body fat development in polycystic ovary syndrome (PCOS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine whether subcutaneous (SC) abdominal adipose aldo-keto reductase 1C3 (AKR1C3; a marker of testosterone generation) is increased in normal-weight women with PCOS vs age- and body mass index (BMI)-matched normoandrogenic ovulatory women (controls) and is related to SC abdominal adipose activator protein-1 (AP-1; a marker of adipocyte differentiation) and\/or androgen receptor (AR) protein expression in predicting fat accretion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Prospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Academic center.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Eighteen normal-weight PCOS women; 17 age- and BMI-matched controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention(s)<\/jats:title>\n                  <jats:p>Circulating hormone\/metabolic determinations, intravenous glucose tolerance testing, total body dual-energy x-ray absorptiometry, SC abdominal fat biopsy, immunohistochemistry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure(s)<\/jats:title>\n                  <jats:p>Clinical characteristics, hormonal concentrations, body fat distribution, SC adipose AKR1C3, AR, and AP-1 protein expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Women with PCOS had significantly higher serum androgen levels and greater android\/gynoid fat mass ratios than controls. SC adipose AKR1C3, AR, and AP-1 protein expressions were comparable between the study groups, but groups differed in correlations. In PCOS women vs controls, SC adipose AKR1C3 protein expression correlated positively with android and gynoid fat masses and negatively with SC adipose AP-1 protein expression. SC adipose AR protein expression correlated negatively with fasting serum free fatty acid and high-density lipoprotein levels. In both study groups, SC adipose AKR1C3 protein expression negatively correlated with serum cortisol levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In normal-weight PCOS women, SC abdominal adipose AKR1C3 protein expression, in combination with intra-adipose AP-1 and AR-dependent events, predicts fat accretion in the presence of physiological cortisol levels.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvae162","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T19:48:59Z","timestamp":1726602539000},"source":"Crossref","is-referenced-by-count":7,"title":["The Subcutaneous Adipose Microenvironment as a Determinant of Body Fat Development in Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0387-1277","authenticated-orcid":false,"given":"Daniel A","family":"Dumesic","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody A","family":"Rasouli","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyneth G","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Dharanipragada","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina F","family":"Turcu","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, Nutrition and Diabetes, University of Michigan , Ann Arbor, MI 48103 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9471-2938","authenticated-orcid":false,"given":"Tristan R","family":"Grogan","sequence":"additional","affiliation":[{"name":"Department of Medicine Statistics Core, University of California, Los Angeles , Los Angeles, CA 90024 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly E","family":"Flores","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara E","family":"Magyar","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-263X","authenticated-orcid":false,"given":"David H","family":"Abbott","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wisconsin National Primate Research Center, University of Wisconsin, Madison , Madison, WI 53715 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio D","family":"Chazenbalk","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, Los Angeles , Los Angeles, CA 90095 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"issue":"5","key":"2024102913412136900_bvae162-B1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"issue":"4","key":"2024102913412136900_bvae162-B2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Repro Update"},{"issue":"11\/12","key":"2024102913412136900_bvae162-B3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-2002-38265","article-title":"Adipose tissue intracrinology: potential importance of local androgen\/estrogen metabolism in the regulation of adiposity","volume":"34","author":"B\u00e9langer","year":"2002","journal-title":"Horm Metab Res"},{"issue":"1-2","key":"2024102913412136900_bvae162-B4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2008.10.035","article-title":"Androgen metabolism in adipose tissue: recent advances","volume":"301","author":"Blouin","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2024102913412136900_bvae162-B5","doi-asserted-by":"crossref","first-page":"111220","DOI":"10.1016\/j.mce.2021.111220","article-title":"AKR1C2 and AKR1C3 expression in adipose tissue: association with body fat distribution and regulatory variants","volume":"527","author":"Ostinelli","year":"2021","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2024102913412136900_bvae162-B6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.1.05762","article-title":"Androgen generation in adipose tissue in women with simple obesity\u2014a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5","volume":"183","author":"Quinkler","year":"2004","journal-title":"J Endocrinol"},{"issue":"9","key":"2024102913412136900_bvae162-B7","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024102913412136900_bvae162-B8","doi-asserted-by":"crossref","first-page":"bvad079","DOI":"10.1210\/jendso\/bvad079","article-title":"Interplay of cortisol, testosterone, and abdominal fat mass in normal-weight women with polycystic ovary syndrome","volume":"7","author":"Dumesic","year":"2023","journal-title":"J Endocr Soc"},{"issue":"11","key":"2024102913412136900_bvae162-B9","doi-asserted-by":"crossref","first-page":"bvab158","DOI":"10.1210\/jendso\/bvab158","article-title":"Serum testosterone to androstenedione ratio predicts metabolic health in normal-weight polycystic ovary syndrome women","volume":"5","author":"Dumesic","year":"2021","journal-title":"J Endocr Soc"},{"issue":"1","key":"2024102913412136900_bvae162-B10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.fertnstert.2020.10.003","article-title":"Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome","volume":"116","author":"Dumesic","year":"2021","journal-title":"Fertil Steril"},{"issue":"7","key":"2024102913412136900_bvae162-B11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.fertnstert.2018.08.042","article-title":"Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight polycystic ovary syndrome women","volume":"110","author":"Fisch","year":"2018","journal-title":"Fertil Steril"},{"issue":"1","key":"2024102913412136900_bvae162-B12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13148-020-00970-x","article-title":"Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming","volume":"12","author":"Leung","year":"2020","journal-title":"Clin Epigenetics"},{"key":"2024102913412136900_bvae162-B13","doi-asserted-by":"crossref","first-page":"102397","DOI":"10.1016\/j.coi.2023.102397","article-title":"AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity","volume":"85","author":"Schnoegl","year":"2023","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"2024102913412136900_bvae162-B14","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism is accompanied by preferential intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024102913412136900_bvae162-B15","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2018-02086","article-title":"Adipose insulin resistance in normal-weight polycystic ovary syndrome women","volume":"104","author":"Dumesic","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024102913412136900_bvae162-B16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr J"},{"issue":"3","key":"2024102913412136900_bvae162-B17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2024102913412136900_bvae162-B18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2013.07.006","article-title":"11\u03b2-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?","volume":"377","author":"Storbeck","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2024102913412136900_bvae162-B19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000486036","article-title":"The rise, fall, and resurrection of 11-oxygenated androgens in human physiology and disease","volume":"89","author":"Turcu","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2024102913412136900_bvae162-B20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2024102913412136900_bvae162-B21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diab.42.2.250","article-title":"Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies","volume":"42","author":"Steil","year":"1993","journal-title":"Diabetes"},{"issue":"7","key":"2024102913412136900_bvae162-B22","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jc.2018-02527","article-title":"11-Oxygenated c19 steroids do not decline with age in women","volume":"104","author":"Nanba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024102913412136900_bvae162-B23","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex differences in 11-oxygenated androgen patterns across adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024102913412136900_bvae162-B24","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024102913412136900_bvae162-B25","volume-title":"Biometry, the Principles and Practice of Statistics in Biological Research","author":"Sokal","year":"1995","edition":"3rd ed"},{"issue":"1-2","key":"2024102913412136900_bvae162-B26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2007.05.015","article-title":"Glucocorticoids, metabolism and metabolic diseases","volume":"275","author":"Vegiopoulos","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2024102913412136900_bvae162-B27","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00039.2008","article-title":"Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis","volume":"296","author":"Blouin","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2024102913412136900_bvae162-B28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2265.2007.02755.x","article-title":"Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity","volume":"66","author":"Wake","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024102913412136900_bvae162-B29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-18-0674","article-title":"Excess androgen production in subcutaneous adipose tissue of women with polycystic ovarian syndrome is not related to insulin or LH","volume":"241","author":"Amer","year":"2019","journal-title":"J Endocrinol"},{"issue":"3","key":"2024102913412136900_bvae162-B30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1210\/jc.2004-031132","article-title":"Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans","volume":"89","author":"Lanfranco","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024102913412136900_bvae162-B31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biochi.2004.11.012","article-title":"Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome","volume":"87","author":"Arner","year":"2005","journal-title":"Biochimie"},{"issue":"3","key":"2024102913412136900_bvae162-B32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1324-0","article-title":"Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots","volume":"47","author":"Dicker","year":"2004","journal-title":"Diabetologia"},{"issue":"5","key":"2024102913412136900_bvae162-B33","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2002-021573","article-title":"Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome","volume":"88","author":"Faulds","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024102913412136900_bvae162-B34","first-page":"1147","article-title":"Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?","volume":"82","author":"Ek","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024102913412136900_bvae162-B35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2013.05.029","article-title":"Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2024102913412136900_bvae162-B36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/me.2014-1062","article-title":"Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues","volume":"28","author":"Patel","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"10","key":"2024102913412136900_bvae162-B37","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2337\/diab.40.10.1228","article-title":"Stimulation of lipolysis in humans by physiological hypercortisolemia","volume":"40","author":"Divertie","year":"1991","journal-title":"Diabetes"},{"key":"2024102913412136900_bvae162-B38","first-page":"182","volume-title":"Steroids in the laboratory and clinical practice","author":"Honour","year":"2023"},{"issue":"7","key":"2024102913412136900_bvae162-B39","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/db16-1320","article-title":"Indirect regulation of endogenous glucose production by insulin: the single gateway hypothesis revisited","volume":"66","author":"Bergman","year":"2017","journal-title":"Diabetes"},{"issue":"5","key":"2024102913412136900_bvae162-B40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-2002-32144","article-title":"Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes","volume":"34","author":"Joyner","year":"2002","journal-title":"Horm Metab Res"},{"issue":"1","key":"2024102913412136900_bvae162-B41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/hep.1840190116","article-title":"Androgen receptor in human liver: characterization and quantitation in normal and diseased liver","volume":"19","author":"Eagon","year":"1994","journal-title":"Hepatology"},{"issue":"5","key":"2024102913412136900_bvae162-B42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ajg.2017.44","article-title":"Testosterone levels in Pre-menopausal women are associated with nonalcoholic fatty liver disease in midlife","volume":"112","author":"Sarkar","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"16","key":"2024102913412136900_bvae162-B43","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2024102913412136900_bvae162-B44","doi-asserted-by":"crossref","first-page":"bqaa061","DOI":"10.1210\/endocr\/bqaa061","article-title":"Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model","volume":"161","author":"Cox","year":"2020","journal-title":"Endocrinology"},{"issue":"2","key":"2024102913412136900_bvae162-B45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pros.20172","article-title":"Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells","volume":"63","author":"Church","year":"2005","journal-title":"Prostate"},{"key":"2024102913412136900_bvae162-B46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biocel.2019.02.005","article-title":"Dihydrotestosterone activates AP-1 in LNCaP prostate cancer cells","volume":"110","author":"Thiel","year":"2019","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"2024102913412136900_bvae162-B47","doi-asserted-by":"crossref","first-page":"e112184","DOI":"10.15252\/embj.2022112184","article-title":"YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth","volume":"42","author":"Li","year":"2023","journal-title":"EMBO J"},{"issue":"6596","key":"2024102913412136900_bvae162-B48","doi-asserted-by":"crossref","first-page":"eabe1505","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"issue":"1","key":"2024102913412136900_bvae162-B49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cmet.2019.10.003","article-title":"TAZ is a negative regulator of PPAR\u03b3 activity in adipocytes and TAZ deletion improves insulin sensitivity and glucose tolerance","volume":"31","author":"El Ouarrat","year":"2020","journal-title":"Cell Metab"},{"issue":"8","key":"2024102913412136900_bvae162-B50","doi-asserted-by":"crossref","first-page":"e72042","DOI":"10.1371\/journal.pone.0072042","article-title":"Lats2 modulates adipocyte proliferation and differentiation via hippo signaling","volume":"8","author":"An","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"2024102913412136900_bvae162-B51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/bies.20676","article-title":"Androgen signaling and its interactions with other signaling pathways in prostate cancer","volume":"29","author":"Kaarb\u00f8","year":"2007","journal-title":"Bioessays"},{"issue":"1","key":"2024102913412136900_bvae162-B52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-022-01149-x","article-title":"Signaling pathways in obesity: mechanisms and therapeutic interventions","volume":"7","author":"Wen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2024102913412136900_bvae162-B53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02801323","article-title":"Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor","volume":"7","author":"Wei","year":"1997","journal-title":"Endocrine"},{"issue":"3","key":"2024102913412136900_bvae162-B54","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbrc.2012.02.074","article-title":"TAZ is downregulated by dexamethasone during the differentiation of 3T3-L1 preadipocytes","volume":"419","author":"He","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"48","key":"2024102913412136900_bvae162-B55","doi-asserted-by":"crossref","first-page":"31853","DOI":"10.1074\/jbc.273.48.31853","article-title":"CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1","volume":"273","author":"Fr\u00f8nsdal","year":"1998","journal-title":"J Biol Chem"},{"issue":"3","key":"2024102913412136900_bvae162-B56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(00)81118-6","article-title":"A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors","volume":"85","author":"Kamei","year":"1996","journal-title":"Cell"},{"issue":"28","key":"2024102913412136900_bvae162-B57","doi-asserted-by":"crossref","first-page":"17485","DOI":"10.1074\/jbc.272.28.17485","article-title":"Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1\/c-Jun in the human prostate cancer cell line LNCaP","volume":"272","author":"Sato","year":"1997","journal-title":"J Biol Chem"},{"issue":"5","key":"2024102913412136900_bvae162-B58","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1073\/pnas.95.5.2122","article-title":"CREB-binding protein in androgen receptor-mediated signaling","volume":"95","author":"Aarnisalo","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024102913412136900_bvae162-B59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1210\/endo.140.1.6418","article-title":"Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1-dissection of the androgen receptor functional domains","volume":"140","author":"Lobaccaro","year":"1999","journal-title":"Endocrinology"},{"issue":"9","key":"2024102913412136900_bvae162-B60","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.steroids.2013.05.001","article-title":"Androgens inhibit adipogenesis during human adipose stem cell commitment to predipocyte formation","volume":"78","author":"Chazenbalk","year":"2013","journal-title":"Steroids"},{"issue":"18","key":"2024102913412136900_bvae162-B61","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1074\/jbc.275.18.13307","article-title":"Human chorionic gonadotropin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 induced by tumor necrosis factor","volume":"275","author":"Manna","year":"2000","journal-title":"J Biol Chem"},{"issue":"24","key":"2024102913412136900_bvae162-B62","doi-asserted-by":"crossref","first-page":"25503","DOI":"10.1074\/jbc.M400683200","article-title":"Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation","volume":"279","author":"ChV","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"2024102913412136900_bvae162-B63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1677\/JOE-06-0101","article-title":"In vitro effects of chorionic gonadotropin hormone on human adipose development","volume":"194","author":"Dos Santos","year":"2007","journal-title":"J Endocrinol"},{"issue":"4","key":"2024102913412136900_bvae162-B64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"issue":"8","key":"2024102913412136900_bvae162-B65","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2337\/diacare.25.8.1351","article-title":"Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin","volume":"25","author":"Palaniappan","year":"2002","journal-title":"Diabetes Care"},{"issue":"6","key":"2024102913412136900_bvae162-B66","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","article-title":"Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome","volume":"98","author":"Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024102913412136900_bvae162-B67","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"issue":"2","key":"2024102913412136900_bvae162-B68","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.1152\/ajpendo.00312.2004","article-title":"Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women","volume":"288","author":"Blouin","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"2024102913412136900_bvae162-B69","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/jc.2003-030240","article-title":"Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates","volume":"88","author":"Tsilchorozidou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2024102913412136900_bvae162-B70","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1093\/nar\/gkx509","article-title":"Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes","volume":"45","author":"Weikum","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2024102913412136900_bvae162-B71","first-page":"347","article-title":"Negative transcriptional regulation by nuclear receptors","volume":"5","author":"Saatcioglu","year":"1994","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"2024102913412136900_bvae162-B72","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/endo.143.3.8678","article-title":"Rapid nongenomic E2 effects on p42\/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes","volume":"143","author":"Dos Santos","year":"2002","journal-title":"Endocrinology"},{"issue":"10","key":"2024102913412136900_bvae162-B73","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1073\/pnas.86.10.3629","article-title":"Mechanism of regulation of the 422(aP2) gene by cAMP during preadipocyte differentiation","volume":"86","author":"Yang","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024102913412136900_bvae162-B74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.psyneuen.2015.03.008","article-title":"Adipocyte glucocorticoid receptors mediate fat-to-brain signaling","volume":"56","author":"de Kloet","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"2024102913412136900_bvae162-B75","doi-asserted-by":"crossref","first-page":"E689","DOI":"10.1152\/ajpendo.00213.2021","article-title":"Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome","volume":"321","author":"Gonz\u00e1lez","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024102913412136900_bvae162-B76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coemr.2020.02.013","article-title":"Endocrine-Metabolic dysfunction in polycystic ovary syndrome: an evolutionary perspective","volume":"12","author":"Dumesic","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"1","key":"2024102913412136900_bvae162-B77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12958-021-00878-y","article-title":"Polycystic ovary syndrome as a plausible evolutionary metabolic adaptation","volume":"20","author":"Dumesic","year":"2022","journal-title":"Repro Biol Endocrinol"},{"issue":"19","key":"2024102913412136900_bvae162-B78","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.3390\/jcm12196120","article-title":"An evolutionary model for the ancient origins of polycystic ovary syndrome","volume":"12","author":"Dumesic","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"2024102913412136900_bvae162-B79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/17446651.2019.1576522","article-title":"Hyperandrogenic origins of polycystic ovary syndrome\u2014implications for pathophysiology and therapy","volume":"14","author":"Abbott","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"2024102913412136900_bvae162-B80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/OGX.0000000000000661","article-title":"Polycystic ovary syndrome: impact of lipotoxicity on metabolic and reproductive health","volume":"74","author":"Brennan","year":"2019","journal-title":"Obstet Gynecol Surv"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvae162\/59157304\/bvae162.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/11\/bvae162\/59992194\/bvae162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/11\/bvae162\/59992194\/bvae162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:41:56Z","timestamp":1730209316000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvae162\/7759648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,9,26]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvae162","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,9,17]]},"article-number":"bvae162"}}